Reimbursement & Investor Strategy
Unlock Funding. Secure Reimbursement. Accelerate Market Adoption.
​
Even the most innovative medical technologies struggle without the right financial and clinical support. Reimbursement and investor strategy are critical levers for success—enabling products to reach patients, gain clinical acceptance, and achieve commercial sustainability. Without a clear pathway, even life-changing innovations risk stagnation.
​
As a Go-To-Market HealthTech Expert with decades of experience, I help MedTech CEOs, founders, and investors align product positioning, reimbursement pathways, and capital strategy to accelerate adoption and scale. My approach integrates clinical, financial, and market intelligence to deliver actionable strategies that maximize impact.
Build a Reimbursement Strategy That Works
Understanding how payors, insurers, and health systems view your technology is key to adoption. I guide organizations through:
​
• Developing reimbursement pathways and coding strategies, including CPT, HCPCS, and DRG codes
• Engaging payors and health systems to validate value propositions and outcomes
• Designing health economics and cost-benefit analyses to support adoption
• Integrating reimbursement considerations early in product development to reduce delays
​
A strong reimbursement strategy ensures your technology not only reaches patients but also generates sustainable revenue for your organization.
Secure Investor Confidence and Funding
Capital fuels innovation, but investors expect a compelling story. I help startups and growing ventures craft:
​
• Investment-ready narratives that clearly communicate market opportunity, clinical value, and competitive advantage
• Polished pitch decks, financial projections, and proforma models that resonate with strategic and financial investors
• Market-making strategies to demonstrate adoption potential, scalability, and ROI
• Guidance on bridging clinical outcomes with investor expectations
​
Successful investor relations go beyond raising capital; they create credibility, strategic partnerships, and long-term growth opportunities.
Align Strategy Across Stakeholders
The intersection of reimbursement and investment is where growth accelerates. My approach ensures alignment among:
​
• Hospitals and health systems adopting your technology
• Payers validating economic and clinical value
• Investors supporting commercialization and scale
• Internal leadership teams executing go-to-market plans
​
This integrated alignment reduces risk, accelerates adoption, and maximizes the probability of market success.
Why Work with Me
With over 20 years in MedTech and experience as a 3× CEO and multiple-time founder, I’ve guided companies from early-stage innovation to global market leadership. Highlights include:
​
• Raised $20M+ in funding for transformative medical technologies
• Launched over 25 medical products worldwide
• Developed award-winning strategies combining commercialization, regulatory compliance, and market access
• Advised hospitals, investors, and executives on successful adoption and scaling
My experience bridges clinical insight, financial strategy, and market execution—ensuring your technology reaches patients and investors with confidence.
